Northwest Biotherapeutics (NWBO) Current Assets (2010 - 2026)
Northwest Biotherapeutics (NWBO) recorded Current Assets of $2.57 million in Q2 2026, down 58.2% from $6.16 million a year earlier and down 58.5% from the prior quarter.
Powered by 
Analysis
Northwest Biotherapeutics (NWBO) Current Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Northwest Biotherapeutics reported Current Assets of $5.52 million, up 35.8% from FY2024.
- Annual Current Assets has a five-year compound annual growth rate of -18.7% (FY2020 to FY2025).
- Across earlier years, Current Assets came in at $4.06 million in FY2024 (-1.5%), $4.13 million in FY2023 (-56.2%), $9.43 million in FY2022 (-45.5%) and $17.29 million in FY2021 (+11.5%).
- The Q2 2026 figure is the lowest quarterly Current Assets since Q3 2018.
- On a year-over-year basis, Current Assets rose in four of the last eight quarters, with growth averaging 3.4%.
- Peak year-over-year performance for Current Assets in the last five years was growth of 86.5% in Q3 2022, against a decline of 58.2% in Q2 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $6.2 million (Q1 2026), $5.52 million (Q4 2025) and $7.2 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,172.56 Bn | 1,141.15 Bn | 19.71 Bn | 64.67 Bn |
| 2 | Johnson & Johnson | 637.42 Bn | 555.95 Bn | 17.26 Bn | 59.77 Bn |
| 3 | AbbVie | 504.13 Bn | 477.24 Bn | 12.70 Bn | 33.67 Bn |
| 4 | Merck | 377.81 Bn | 332.19 Bn | 12.21 Bn | 36.68 Bn |
| 5 | Novartis Ag | 304.36 Bn | 268.35 Bn | 11.24 Bn | 27.35 Bn |
| 6 | Astrazeneca | 267.51 Bn | 241.20 Bn | 12.86 Bn | 27.97 Bn |
| 7 | Amgen | 242.18 Bn | 197.58 Bn | 7.24 Bn | 34.96 Bn |
| 8 | Gilead Sciences | 194.29 Bn | 168.48 Bn | 6.22 Bn | 13.95 Bn |
| 9 | Pfizer | 172.82 Bn | 119.47 Bn | 10.94 Bn | 41.36 Bn |
| 10 | Northwest Biotherapeutics | 257.86 Mn | 247.88 Mn | - | 2.57 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.57 Mn |
| Mar 31, 2026 | 6.20 Mn |
| Dec 31, 2025 | 5.52 Mn |
| Sep 30, 2025 | 7.20 Mn |
| Jun 30, 2025 | 6.16 Mn |
| Mar 31, 2025 | 4.69 Mn |
| Dec 31, 2024 | 4.06 Mn |
| Sep 30, 2024 | 5.19 Mn |
| Jun 30, 2024 | 4.98 Mn |
| Mar 31, 2024 | 4.95 Mn |
| Dec 31, 2023 | 4.13 Mn |
| Sep 30, 2023 | 8.45 Mn |
| Jun 30, 2023 | 4.64 Mn |
| Mar 31, 2023 | 9.49 Mn |
| Dec 31, 2022 | 9.43 Mn |
| Sep 30, 2022 | 11.76 Mn |
| Jun 30, 2022 | 7.18 Mn |
| Mar 31, 2022 | 9.27 Mn |
| Dec 31, 2021 | 17.29 Mn |
| Sep 30, 2021 | 6.31 Mn |
API Access
Northwest Biotherapeutics Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=NWBO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "NWBO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=NWBO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();